Xylem Aktie
112,05
EUR
-0,30
EUR
-0,27
%
116,63
USD
-0,29
USD
-0,25
%
Xylem Aktie Analyse
14.05.19 | Xylem Market Perform | Cowen and Company, LLC | |
19.12.18 | Xylem Buy | Stifel, Nicolaus & Co., Inc. | |
04.08.17 | Xylem Outperform | BMO Capital Markets | |
02.08.17 | Xylem Outperform | RBC Capital Markets | |
23.06.17 | Xylem Outperform | BMO Capital Markets | |
15.05.17 | Xylem overweight | Barclays Capital | |
03.02.17 | Xylem Outperform | Boenning & Scattergood | |
03.02.17 | Xylem Outperform | RBC Capital Markets | |
Werbung
|
|||
01.02.17 | Xylem Hold | Gabelli & Co | |
02.11.16 | Xylem Hold | Stifel, Nicolaus & Co., Inc. | |
04.05.16 | Xylem Neutral | Wedbush Morgan Securities Inc. | |
11.04.16 | Xylem Neutral | Wedbush Morgan Securities Inc. | |
21.03.16 | Xylem Hold | Stifel, Nicolaus & Co., Inc. | |
06.01.16 | Xylem Outperform | RBC Capital Markets | |
02.11.15 | Xylem Equal weight | Barclays Capital | |
28.09.15 | Xylem Outperform | Oppenheimer & Co. Inc. | |
03.09.15 | Xylem Buy | Stifel, Nicolaus & Co., Inc. | |
31.07.15 | Xylem Equal weight | Barclays Capital | |
08.07.15 | Xylem Accumulate | Global Hunter Securities | |
15.06.15 | Xylem Outperform | Oppenheimer & Co. Inc. | |
01.04.15 | Xylem Outperform | Boenning & Scattergood | |
28.01.15 | Xylem Neutral | Boenning & Scattergood | |
05.01.15 | Xylem Hold | Stifel, Nicolaus & Co., Inc. | |
25.11.14 | Xylem Sector Perform | RBC Capital Markets | |
29.10.14 | Xylem overweight | Barclays Capital | |
14.12.12 | Xylem kaufen | Fuchsbriefe | |
18.10.12 | Xylem neutral | Ladenburg Thalmann & Co. Inc. |